Two years ago, Govind Sandhu was living what he thought was an optimised life when he was diagnosed with blood cancer at 38.

Mimrylo was cleared to treat polycythemia vera, a chronic blood cancer in which overproduction of red blood cells thickens a ...

One brush stroke at a time, Rosalind Gauchat, 65, is creating something cancer once threatened to steal: peace, purpose and a ...

Human trials and population data point to real, if modest, effects from a kitchen staple.

When red blood cells break down, they release heme, a component of hemoglobin that can contribute to inflammation and damage ...

Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as ...

Researchers at the University of California San Diego School of Medicine have been awarded a contract of up to $11.312 ...

Potassium helps regulate fluids in your body and is a key factor in maintaining healthy blood pressure. Fruits like avocado, ...

FDA approves Mimrylo (rusfertide) for adults with polycythemia vera, offering a new treatment approach that may reduce the ...

Why low vitamin or nutrient levels could be at the root of your extreme fatigue, soreness, and performance decline.

The U.S. Food and Drug Administration (FDA) has granted fast-track designation to CK0803, an experimental T-cell therapy from Cellenkos that’s currently in Phase 1 clinical testing for people with ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...